| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4904f1ae17f6bdcd9ea8dc450d95515f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee0b54f4d2991760c71d9fd631ac707f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2ab1b9ddd164ffb9c02845958dc1e91 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2012-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e75f1811988f02545cca18492a9c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12c812bd559710b17c8b96700d6ca5ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f961be852c9529f8d0b9ff063cfcd5 |
| publicationDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013016675-A1 |
| titleOfInvention |
Dendritic cell (dc)-vaccine therapy for pancreatic cancer |
| abstract |
Compositions and methods for eliciting therapeutic immunity and improving clinical outcomes in patients with pancreatic cancer are disclosed herein. The present invention describes a dendritic cell (DC)-vaccine comprising DCs pulsed with peptides derived from pancreatic cancer antigens for the therapy against pancreatic cancer. The vaccine described herein is safe, and leads to expansion of cancer specific T cells in patients with pancreatic cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021220458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015132806-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017152008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4092112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3658158-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11555192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3374496-A4 |
| priorityDate |
2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |